China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)

Market Cap	21.94B
Revenue (ttm)	10.31B
Net Income (ttm)	1.39B
Shares Out	1.03B
EPS (ttm)	1.36
PE Ratio	15.70
Forward PE	12.16
Dividend	0.20 (0.94%)
Ex-Dividend Date	Jul 15, 2024

Volume	9,608,873
Open	21.57
Previous Close	21.67
Day's Range	21.28 - 21.85
52-Week Range	14.80 - 24.13
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About China Resources Double-Crane Pharmaceutical Co.,Ltd.

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 12,269
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2023, 600062's revenue was 10.22 billion, an increase of 6.20% compared to the previous year's 9.63 billion. Earnings were 1.33 billion, an increase of 12.96%.